| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,974 |
2,357 |
$636K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
937 |
741 |
$295K |
| 80053 |
Comprehensive metabolic panel |
3,723 |
3,330 |
$167K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
692 |
601 |
$109K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
377 |
368 |
$109K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
122 |
106 |
$78K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,017 |
231 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,627 |
3,257 |
$73K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
242 |
191 |
$39K |
| 36415 |
Collection of venous blood by venipuncture |
5,025 |
4,267 |
$39K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
151 |
124 |
$28K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
335 |
268 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
139 |
131 |
$15K |
| 86140 |
|
741 |
682 |
$12K |
| 85652 |
|
592 |
545 |
$9K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
82 |
71 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
89 |
79 |
$8K |
| 81002 |
|
1,069 |
1,000 |
$7K |
| 86738 |
|
128 |
126 |
$6K |
| 0001A |
|
88 |
85 |
$6K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
34 |
25 |
$6K |
| 86710 |
|
200 |
97 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
266 |
257 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
318 |
309 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
31 |
26 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
47 |
44 |
$4K |
| 91300 |
|
142 |
127 |
$4K |
| 0002A |
|
76 |
75 |
$4K |
| 80061 |
Lipid panel |
135 |
132 |
$3K |
| 0003A |
|
24 |
24 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
35 |
33 |
$3K |
| 86677 |
|
77 |
74 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
53 |
50 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
30 |
28 |
$2K |
| 87430 |
|
37 |
36 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
65 |
56 |
$1K |
| 97162 |
|
15 |
13 |
$1K |
| A9570 |
Indium in-111 labeled autologous white blood cells, diagnostic, per study dose |
117 |
32 |
$1K |
| 82805 |
|
16 |
13 |
$875.36 |
| 81000 |
|
107 |
98 |
$831.34 |
| 94760 |
|
30 |
24 |
$729.07 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
42 |
40 |
$726.56 |
| 87070 |
|
45 |
42 |
$718.34 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
32 |
28 |
$685.95 |
| 87077 |
|
30 |
29 |
$471.98 |
| 87186 |
|
14 |
13 |
$264.16 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
18 |
13 |
$251.63 |
| 83721 |
|
12 |
12 |
$197.99 |
| 85032 |
|
12 |
12 |
$178.67 |
| 85610 |
|
23 |
15 |
$172.42 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
19 |
18 |
$162.97 |
| 83735 |
|
18 |
13 |
$143.37 |